• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/16

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

16 Cards in this Set

  • Front
  • Back

What is the Incidence of penile cancer?

 Overall Incidence (Squamous Cell Carcinoma) 0.1 – 8.3 per 100,000 males


 Europe & USA <1 per 100,000


(Europe 0.0 – 0.9 USA 0.7 – 0.9)


 UK
NCIN reports incidence 1.3-2.0 per 100 000 between 2008-10


 Asia/Africa/South America 4.2- 8.3 per 100,000


What are the risk factors for penile cancer?

 Non-Circumcision / Phimosis


 HPV infection


 Smoking


 Age


 Sexually Transmitted Infections

Why does circumcision protect against penile cancer?

Non-Circumcision / Phimosis


 Protective effect of circumcision thought to be due to improved hygiene, reduced smegma retention and prevention of phimosis


 Lowest incidence of penis cancer: Israel


 Greater resistance to HPV infection in circumcised


men


 Lower incidence of infection or trauma

What is the link between penile cancer and HPV?

 Not universal as in Cervical Cancer


 High Risk HPV DNA variably detected in Penile


cancers; 30% to 100%


 Systematic reviews found 40-48% of penile cancers are HPV related


 hrHPV types 16, 18

Does smoking cause penile cancer?

Yes


Smoking


 Consistently reported increases risk


 Dose depedent


 Chewing tobacco equally a risk


 Exact role not clearly known

What are the premalignant lesions in penile cancer?

 HPV Related


 Giantcondyloma(Bushke-LowensteinTumour) coalesce in large exophytic tumour, malignant change 30% (HPV 6&11)


 Bowen’sDisease Progression 5% HPV 16


 Erythroplasia of Queyrat progression 30%


 Bowenoid papulosis contagious <1% progression


 Non HPV related  LichenSclerosis  Leukoplakia 10-20% dysplastic changes
 Cutaneoushorn progression 30%

What is the treatment of premalignant lesions?

Pre-treatment biopsy essential


 Circumcision


 primary treatment of disease solely confined to foreskin


 adjuncttoothernon-surgicaltreatments


 Topical therapy


 5FU


 Imiquimod


 Laser/Cryotherapy/PDT


 Surgical excision


 WLE
 Glansresurfacing

What is the 2009 TNM clinical classification of penile cancer?

Tis Carcinoma in situ


Ta Non-invasive verrucous carcinoma, not associated with destructive invasion T1 Tumour invades subepithelial connective tissue


T1a Tumour invades subepithelial connective tissue without lymphovascular invasion and is not poorly differentiated or undifferentiated (T1G1-2)


T1b Tumour invades subepithelial connective tissue without with lymphovascular


invasion or is poorly differentiated or undifferentiated (T1G3-4) T2* Tumour invades corpus spongiosum/corpora cavernosa


T3 Tumour invades urethra


T4 Tumour invades other adjacent structures


N1 - 1 ing node


N2 - multiple or b/l ing nodes


N3 - Fixed ing nod or pelvi node


M1 distant mets

What are the histological variants of SCC?

Types of SCC


• Classic
• Basaloid
• Verrucous and its varieties:


- Warty (condylomatous) carcinoma - Verrucous carcinoma
- Papillary carcinoma
- Hybrid verrucous carcinoma


- Mixed carcinomas (warty basaloid and adenobasaloid carcinoma)


• Sarcomatoid
• Adenosquamous


Growth patterns of SCC


• Superficial spread
• Nodular or vertical-phase growth • Verruciform

Is there a role for radiotherapy in penile cancer?

 Small tumours <4cm


 T1-2


 Usually external beam, but brachytherapy available


 Local failure higher than in partial penectomy, but can achieve local control 70+%


 Problems with meatal stenosis (20-35%), glans necrosis (10%), skin changes which may make surveillance difficult


 Rarely given

What are the principles and indications of glansectomy?

 Glans penis can be mobilised off corporal heads maintaining maximal penile length with good cosmesis and function


 Can be resurfaced with SSG or primarily closed with prepuce


 Partial glansectomy with smaller lesions


 Suitable for T1 and early T2 disease not infiltrating corpus cavenosal heads

What is the 5 year survival for patient with node disease?

5 year survival of ~80% has been reported in patients with single nodal involvement


95% node negative Vs 53% node positive (Ravi)

In a node positive penile cancer patient when is the best time to operate?

Kroon et al: J Urol 2005
 20 patients Groin dissections following DSNB vs 20


patients Groin dissection after surveillance  3yearsurvival84%vs35%


 Several studies have similarly shown improved survival in patients undergoing early vs delayed therapeutic node dissections ( Ravi 1993, Srinivas et al 1987, Fraley et al 1989)

What are the boundaries and complications of a standard in LND?

Standard lymphadectomy boundaries: -Inguinal ligament
-Sartorius
-Adductor Longus


-Apex femoral triangle


Significant Morbidity -Wound Infection: 3-70% -Necrosis: 2.5-64% -Seroma: 5-84% -Lymphoedema: 5-100%

What are the boundaries of the modified Ing LND?

Modified lymphadectomy to reduce morbidity of groin node dissection; Catalona 1988


Boundaries
-External oblique above Spermatic Cord -Lateral border femoral artery
-Adductor Longus
-Lower end fossa ovalis
-Saphenous vein spared


Significant Morbidity -Wound Infection: 7% -Necrosis: 4% -Seroma: 14% -Lymphoedema: 18%

What is the role of chemotherapy in penile cancer?

Not clearly established


 Small non-randomised studies


 Palliative


 Neo-adjuvant to down-stage inoperable groin nodes


 InPACT study due (International Penile Advanced Cancer Trial)